You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 5, May 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 69TH ANNUAL MEETING OF THE NEW ENGLAND SURGICAL SOCIETY, MONTREAL, CANADA, SEPT 15 TO SEPT 17, 1988
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Primary Cancer of the Liver

Evaluation, Treatment, and Prognosis

William V. McDermott, MD; Blake Cady, MD; Basil Georgi, MD; Glenn Steele, Jr, MD; Urmila Khettry, MD

Arch Surg. 1989;124(5):552-555.


Abstract

• Between 1970 and 1985, a diagnosis of primary hepatocellular carcinoma was established in 98 patients. Sixty-one cases developed in the presence of chronic liver disease, and only six of these were considered resectable. Of these, the median survival was 19 months. There was one perioperative death. Of the 98 tumors, 37 arose in normal livers. Of the 16 patients with tumors in normal livers that were resected, all survived operation. The long-term median survival was 32 months. Two subsets of the fibrolamellar and clear-cell variants appeared to carry a more favorable prognosis.

(Arch Surg. 1989;124:552-555)



Author Affiliations

From the Departments of Surgery, Harvard Medical School, and New England Deaconess Hospital, Boston, Mass.


Footnotes

Accepted for publication December 7, 1988.

Read before the 69th Annual Meeting of the New England Surgical Society, Montreal, Canada, September 18, 1988.

Reprint requests to Department of Surgery, New England Deaconess Hospital, 110 Francis St, 3A, Boston, MA 02215 (Dr McDermott).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Nonresectable Hepatocellular Carcinoma with Intrahepatic 90Y-Microspheres
Dancey et al.
JNM 2000;41:1673-1681.
ABSTRACT | FULL TEXT  

Noninvasive Evaluation of Cytochrome c Oxidase Activity of the Liver: Its Prognostic Value for Hepatic Resection
Ueda et al.
Arch Surg 1994;129:303-308.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.